Carregant...
PATH-48. FUSION TESTING IN ADULT VERSUS PEDIATRIC LOW AND HIGH GRADE BRAIN TUMORS FOR ELIGIBILITY FOR TRIALS
BACKGROUND: Since January 2017, our molecular laboratory has assessed 47 pediatric and 23 adult primary brain tumors for fusions that might result in novel treatment; adults with glioblastoma (GBM) had been screened specifically for the STARTRK-2 study. This trial has open arms for patients whose tu...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216931/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.702 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|